Nanologica
5.54 SEK -1.07%1 investor is following this company
Nanologica is a biotechnology company that develops, manufactures, and sells nanoporous silica particles for life science applications. The company has two business areas: chromatography, which is an analysis and purification technique in the pharmaceutical industry used, for example in insulin, and drug development where the company develops an inhalation platform to deliver drugs locally in the lung. Nanologica was founded in 2004 and is headquartered in Södertälje.
Revenue
1.44M
EBIT %
-4,858.33 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
NICA
Daily low / high price
5.44 / 5.58
SEK
Market cap
244.75M SEK
Turnover
47.06K SEK
Volume
8.6K
Financial calendar
General meeting
2024-05-16
Interim report
2024-07-05
Interim report
2024-10-25
Annual report
2025-02-07
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Flerie Invest AB | 41.2 % | 41.2 % |
Swedbank Robur Microcap | 6.4 % | 6.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Number of Shares and Votes in Nanologica AB (publ)
Redeye: Nanologica Q1 2024 - Mixed start of the year
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools